News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Sergio Cifuentes: The Clinico-genomic Landscape and Outcomes of KRAS G12C–Mutated Pancreatic Cancer
Sergio Cifuentes Canabal/LinkedIn
Sep 24, 2024, 14:18

Sergio Cifuentes: The Clinico-genomic Landscape and Outcomes of KRAS G12C–Mutated Pancreatic Cancer

Sergio Cifuentes, Cancer Research Project Manager at CENEIT Mexico, shared on X:

“Check out my latest Insights – Characterizing the Clinico-genomic Landscape and Outcomes of KRAS G12C–Mutated Pancreatic Cancer.

Characterizing the Clinico-genomic Landscape and Outcomes of KRAS G12C–Mutated Pancreatic Cancer

  • Prevalence: KRAS is the most common oncogene alteration in pancreatic ductal adenocarcinoma, and KRAS G12Cmut found in 1%-2% of pancreatic ductal adenocarcinoma cases.

Key Findings

  • The median age of the patients was 67, with 56% being female and a median BMI of 29.2 kg/m2. Sixty-seven percent had smoked at some point in their lives.
  • Survival Rates: Median overall survival was 13 months for stage IV and 26 months for stage I-III.
  • Commonly co-altered genes: TP53 (73%), CDKN2A (33%), SMAD4 (28%), and ARID1A (21%).
  • Overall survival did not differ between KRAS G12Cmut and non-G12C KRAS pancreatic ductal adenocarcinoma.

Clinical Implications

  • Distinct Phenotype: KRAS G12Cmut linked to unique clinical characteristics in pancreatic cancer.
  • Genomic Similarities: Resemblance to non-G12C KRAS mutations, highlighting the significance of ARID1A co-mutations.
  • Treatment Potential: Targeting KRAS G12C sets the stage for broader KRAS-focused therapies in pancreatic cancer.”

Sergio Cifuentes

Precision medicine for pancreatic cancer: characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated disease 

Authors: Fergus Keane, Joanne F Chou, Henry Walch, Joshua Schoenfeld, Anupriya Singhal, Darren Cowzer, Emily Harrold, Catherine A O’Connor, Wungki Park, Anna Varghese, Imane El Dika, Fiyinfolu Balogun, Kenneth H Yu, Marinela Capanu, Nikolaus Schultz, Rona Yaeger, Eileen M O’Reilly,

Sergio Cifuentes

Source: Sergio Cifuentes/X

 

Anna Varghese Anupriya Singhal cancer Catherine A. O’Connor Darren Cowzer Eileen M. O'Reilly Emily Harrold Fergus Keane Fiyinfolu Balogun Henry Walch Imane El Dika Joanne F. Chou Joshua Schoenfeld Kenneth H Yu KRAS G12C–Mutated Pancreatic Cancer Marinela Capanu Nikolaus Schultz OncoDaily Oncology Pancreatic Cancer Rona Yaeger Sergio Cifuentes Wungki Park
Special Coverage
Blog
Dec 21, 2024, 14:10
Arif Kamal: Ensuring all people have access to the cancer navigation services that will help them live more and better days
Blog
Dec 21, 2024, 14:06
The Accelerate 2025 Annual Conference Agenda Is Here!
Blog
Dec 21, 2024, 14:03
Pioneer the future of discovery and innovation with a fully funded Bicentenary PhD Studentship at The University of Manchester
Blog
Dec 21, 2024, 14:00
NCI Division of Cancer Prevention - DHT Derived Biomarkers and COAs for Remote Monitoring and Endpoint Development
Blog
Dec 21, 2024, 13:51
The ESMO President Letter emphasises the importance of collective action to shape the future of oncology
Blog
Dec 21, 2024, 13:48
Overcoming recurrence: How research is bringing new hope for breast cancer patients - The Institute of Cancer Research
Blog
Dec 21, 2024, 13:46
IARC - Cancer Incidence in Five Continents, Vol XII
Blog
Dec 21, 2024, 13:43
National University Cancer Institute, Singapore clinicians had the exciting opportunity to present their work at the ESMO Asia 2024
Blog
Dec 21, 2024, 13:40
UICC - Welcoming the newest member, The World Hepatitis Alliance
Blog
Dec 21, 2024, 13:35
Pediatric Cancer and Blood Disorders Center of Armenia - Prioritizing the continuous education and knowledge exchange of the medical staff
Blog
Dec 21, 2024, 13:33
SIOP Europe - International Childhood Cancer Day 2025
Blog
Dec 21, 2024, 13:29
Canadian Cancer Society - How 5 organizations are working to take on cancer’s biggest issues